T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Restricted use of T cell receptor (TCR) gene segments is characteristic of several induced autoimmune disease models. TCR sequences have previously been unavailable for pathogenic T cells which react with a defined autoantigen in a spontaneous autoimmune disease. The majority of T cell clones, derived from islets of NOD mice which spontaneously develop type I diabetes, react with insulin peptide B-(9-23). We have sequenced the alpha and beta chains of TCRs from these B-(9-23)-reactive T cell clones. No TCR beta chain restriction was found. In contrast, the clones (10 of 13) used V alpha13 coupled with one of two homologous J alpha segments (J alpha45 or J alpha34 in 8 of 13 clones). Furthermore, 9 of 10 of the V alpha13 segments are a novel NOD sequence that we have tentatively termed V alpha13.3. This dramatic alpha chain restriction, similar to the beta chain restriction of other autoimmune models, provides a target for diagnostics and immunomodulatory therapy.

[1]  H. Wekerle,et al.  T cell receptor β chain usage in myelin basic protein‐specific rat T lymphocytes , 1989 .

[2]  D. Wegmann,et al.  Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Kikutani,et al.  T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice , 1991, The Journal of experimental medicine.

[4]  A. Rostami,et al.  Shared T‐cell receptor gene usage in experimental allergic neuritis and encephalomyelitis , 1992, Annals of neurology.

[5]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[6]  L. Hood,et al.  Characterization of the T cell receptor repertoire causing collagen arthritis in mice , 1993, The Journal of experimental medicine.

[7]  C. Fathman,et al.  Genetic dissection of T cell receptor V beta gene requirements for spontaneous murine diabetes , 1991, The Journal of experimental medicine.

[8]  L. Hood,et al.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.

[9]  M. Dorf,et al.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.

[10]  V. Brusic,et al.  Similar Peptides from Two β Cell Autoantigens, Proinsulin and Glutamic Acid Decarboxylase, Stimulate T Cells of Individuals at Risk for Insulin-Dependent Diabetes , 1995, Molecular medicine.

[11]  M. A. Bowman,et al.  Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. , 1994, Immunology today.

[12]  M. Mcduffie Diabetes in NOD Mice Does not Require T Lymphocytes Expressing Vβ8 or Vβ5 , 1991, Diabetes.

[13]  R. Gill,et al.  Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.

[14]  D. Wegmann,et al.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.

[15]  C. Benoist,et al.  Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Tompkins,et al.  An insulin peptide that binds an alternative site in class II major histocompatibility complex , 1996, The Journal of experimental medicine.

[17]  J. Seidman,et al.  Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. , 1993, Science.

[18]  S. Fling,et al.  Conserved T cell receptor V gene usage by uveitogenic T cells. , 1991, Clinical immunology and immunopathology.

[19]  J. Bach Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. , 1995, Journal of autoimmunity.

[20]  T. Utsugi,et al.  Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. , 1995, Journal of immunology.

[21]  J. Krischer,et al.  Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. , 1995, The Journal of clinical investigation.

[22]  D. Wegmann,et al.  Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.